Sidebilder
PDF
ePub

NARD OFFICERS
JOHN W. WHITE, P.D., PRESIDENT

1335 EAST 6TH AVE, TALLAHASSEE, FL 32303
H. JOSEPH SCHUTTE, P.D., PRESIDENT-ELECT

3309 COLLEGE DRIVE, LOUISVILLE, KY 40299 LAWRENCE E. SCHREIBER, JR., P.D., FIRST VICE PRES

2805 NEWBRIDGE COURT, ST LOUIS, MO 63129
WILLIAM L. SCHARRINGHAUSEN, P.D., SECOND VICE PRESIDENT

BOX 29-D, PARK RIDGE, IL 60068
JOHN H. VANDEL, P.D., FOURTH VICE PRESIDENT

2041 MAIN STREET, TORRINGTON, WY 82240
DONALD L. MOORE, P.D., FIFTH VICE PRESIDENT

610 WEST MARKLAND AVE, KOKOMO, IN 46901 ED DRUCKER, P.D., SECRETARY-TREASURER 16139

MORRISON ST ENCINO, CA 91436

NARD EXECUTIVE COMMITTEE
LONNIE F. HOLLINGSWORTH, P.D., CHAIRMAN

5119-34TH ST., LUBBOCK, TX 79410
DARWYN J. WILLIAMS, P.D.

611 SECOND ST, WEBSTER CITY, IA 50595 DONALD W. ARTHUR, P.D.

356 SOMERVILLE, TONAWANDA, NY 14150 JOSEPH A. MOSSO, P.D.

319 CAROLYN AVE., LATROBE, PA 15650 WILLIAM S. KATZ, P.D.

26 STAGE COACH LANE, NEWINGTON, CT 06111 CALVIN J. ANTHONY, P.D.

825 WALNUT STREET, STILLWATER, OK 74074

CHARLES M. WEST, P.D.
EXECUTIVE VICE PRESIDENT

THE NATIONAL ASSOCATION OF RETAIL DRUGGISTS

205 DAINGERFIELD ROAD, ALEXANDRIA, VA 22314

(703) 683-8200

STATEMENT

OF

THE NATIONAL ASSOCIATION OF RETAIL DRUGGISTS

BEFORE THE

COMMITTEE ON THE JUDICIARY

UNITED STATES SENATE

ON

THE DESIGNER DRUG ENFORCEMENT ACT OF 1985

S.1437

WITNESSES:

JOHN W. WHITE
PRESIDENT

JOHN M. RECTOR, ESQ.
DIRECTOR OF GOVERNMENT AFFAIRS

99th CONGRESS
lst Session

HEARING ON SEPTEMBER 18, 1985

WASHINGTON, DC

STATEMENT OF THE NATIONAL ASSOCIATION OF RETAIL DRUGGISTS

BEFORE THE SENATE COMMITTEE ON THE JUDICIARY

THE DESIGNER DRUG ENFORCEMENT ACT OF 1985

September 18, 1985

Mr. Chairman, Members of the Committee:

I am John W. White of Tallahassee, Florida. I serve as President of the National Association of Retail Druggists. with me today is John Rector, our Director of Government Affairs.

The National Association of Retail Druggists (NARD) represents owners of more than 30,000 independent pharmacies, where over 75,000 pharmacists dispense more than 70 percent of the nation's

1 prescription drugs. Together, they serve 18 million persons daily. 1 NARD has long been acknowledged as the sole advocate for this vital component of the free-enterprise system.

NARD members are primarily family businesses. They have roots in America's communites. The neighborhood independent druggist typifies the reliability, stability, yet adventuresomeness, that has made our country great.

We are especially pleased to present our views to the Committee on proposed amendments to the Controlled Substances Act, which will create new penalties for the manufacturing with intent to distribute, the possession with intent to distribute, or the distribution of "designer drugs", and for other purposes.

We would like to express our special appreciation to the Committee, its Chairman, and Staff for their thorough but expeditious

eration of this important legislation.

[ocr errors]

I In 1982, independents filled 1,039,893,000 and chains filled 421,989,000 prescriptions of the total prescriptions (1,461,822,000) filled in the U.S. The average prescription price in 1982 for independents was $8.22 and for chains $8.29. of the 210,493,000 prescriptions filled under the Medicaid program, chains filled 34,849,000 and independents filled 175,644,000. See American Druggist prescription survey May 1983.

2Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, P.L. 91-513, 84 Stat 1736, enacted 10/27/70, effective 5/1/71, is known as the Controlled Substances Act (21 USC 801 et.seq.).

[blocks in formation]

THIS BOOK IS DUE ON THE LAST DATE STAMPED BELOW
Books not returned on time are subject to fines according

to the Library Lending Code.
Books cannot be renewed by phone.
Books may be recalled at any time.

[ocr errors][merged small][merged small]

years, or both sanctions, s.1437 will, in our view, provide an important deterrent for any person who knowingly, or intentionally manufactures with intent to distribute, possesses with intent to

distribute, or distributes designer drugs for human consumption. Additionally, we strongly endorse provisions which make these new penalties inapplicable to a person who manufactures or distributes a substance in conformance with provisions of an Approved New Drug Application or an exemption for investigational use.

Designer drugs are extremely dangerous from a health standpoint. The drugs are thousands of times more potent than the illegal narcotics presently flooding the country, and over a hundred deaths have been identified with designer drug use so far. Furthermore, these drugs have been responsible for causing longterm neurodegenerative diseases in some users. The human and medical economic costs of designer drugs are potentially devastating. It is our hope that s.1437 will be a valuable tool in the law enforcement effort to curb traffic and abuse of designer drugs. In conclusion, Mr. Chairman, we commend you for your strong

3 support of s.1437 and each of the co-sponsors of the legislation. I am especially proud of our two Florida Senators, Mrs. Hawkins and Mr. Chiles, who have provided national leadership on the problem of designer drugs.

Again, on behalf of the Officers, Executive Committee, and members of the National Association of Retail Druggists, we thank you for the opportunity to appear and continue to participate in the formulation of appropriate Federal drug diversion policy.

3 's.1437, To amend the Controlled Substances Act to create new penalties for the manufacturing with intent to distribute, the possession with intent to distribute, or the distribution of "designer drugs", and for other purposes. In the Senate of the United States, July 16, 1985 by Mr. Thurmond (for himself, Mrs. Hawkins, Mr. Chiles, Mr. Biden, Mr. DeConcini, Mr. Simpson, Mr. Cochran, Mr. Murkowski, and Mr. Specter) referred to the Committee on the Judiciary.

[merged small][ocr errors]
[graphic]
« ForrigeFortsett »